Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 18, 2018 - Issue 5
Submit an article Journal homepage
493
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Uptake of rheumatology biosimilars in the absence of forced switching

Daniela Di GiuseppeClinical Epidemiology unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]
View further author information
,
Thomas FrisellClinical Epidemiology unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, SwedenView further author information
,
Sofia ErnestamDepartment of Rheumatology, Karolinska University Hospital, Stockholm, SwedenView further author information
,
Helena Forsblad-D’EliaDepartment of Public Health and Clinical Medicine, Rheumatology, Umeå University, Umeå, SwedenView further author information
,
Elisabet LindqvistSection of Rheumatology, IKVL, Lund University and Skåne University hospital, Lund, SwedenView further author information
,
Ulf LindströmRheumatology and Inflammation Research, Sahlgrenska Academy, Gothenburg University, Gothenburg, SwedenView further author information
,
Christopher SjöwallRheumatology/Division of Neuro and Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenView further author information
&
Johan AsklingClinical Epidemiology unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;Department of Rheumatology, Karolinska University Hospital, Stockholm, SwedenView further author information
 show all
Pages 499-504 | Received 12 Feb 2018, Accepted 23 Mar 2018, Published online: 10 Apr 2018

References

  • Goldenberg MM. Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis. Clin Ther. 1999 Jan;21(1):75–87; discussion 1-2. PubMed PMID: 10090426; eng.
  • Jacobs I, Petersel D, Isakov L, et al. Biosimilars for the treatment of chronic inflammatory diseases: a systematic review of published evidence. BioDrugs. 2016 Dec;30(6):525–570. PubMed PMID: 27885553; PubMed Central PMCID: PMCPMC5126192. eng.
  • Lunddahl B. Pharmacovigilance on biologicals and biosimilars: a Danish perspective. GaBI J. 2016;5:123–124.
  • Glintborg B, Sørensen IJ, Loft AG, et al. A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry. Ann Rheum Dis. 2017 May 04;76:1426–1431.
  • Eriksson JK, Neovius M, Ernestam S, et al. Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res (Hoboken). 2013 Jun;65(6):870–878. PubMed PMID: 23281173; eng.
  • Neovius M, Simard JF, Askling J, et al. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis. 2011 Apr;70(4):624–629. PubMed PMID: 21149495; eng.
  • Exarchou S, Lindstrom U, Askling J, et al. The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study. Arthritis Res Ther. 2015 May 09;17:118. PubMed PMID: 25956915; PubMed Central PMCID: PMCPMC4424886.
  • Lofvendahl S, Theander E, Svensson A, et al. Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden–a population-based register study. PLoS One. 2014;9(5):e98024. PubMed PMID: 24875275; PubMed Central PMCID: PMCPMC4038520.
  • Wadström H, Eriksson JK, Neovius M, et al. How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)? Scand J Rheumatol. 2015;44(1):22–28. PubMed PMID: 25379815; eng.
  • Bonovas S, Peyrin-Biroulet L, Danese S. Clinical development of biologicals and biosimilars - safety concerns. Expert Rev Clin Pharmacol. 2017 Jun;10(6):567–569. PubMed PMID: 28475378.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.